Immuno-Oncology 360° 2022 Summit
IO360˚convenes stakeholders from the science and business communities to report on the latest data impacting IO to fight a wider range of cancers.
Read more
Festival of Biologics USA 2022
Speaker: Li Hui M.D., Ph.D., Director, Antibody Discovery & RenMice Licensing, Biocytogen Boston Corp Time: 5:10pm PST, March 9th Talk title: Streamlining Therapeutic Antibody Discovery…
Read more
Webinar: Mouse Models to Investigate New Treatments for Inflammatory Disease
We’re pleased to continue our new webinar series informing and updating our network of research professionals. We invite you to join us to learn about…
Read more
Webinar: Investigating Inflammatory Disease using Humanized Cytokine Mice
Our webinar “Investigating Inflammatory Disease using Humanized Cytokine Mice” was live on Dec 1, 2021 at 1PM. In this webinar, we will: - Review the…
Read more
Webinar: Advancing T cell Therapies Using B-hCD3 Mouse Models
We are pleased to launch a new webinar series! Our webinar “Advancing T cell Therapies Using B-hCD3 Mouse Models” was live on Oct 28 at…
Read more
Biocytogen/Eucure Biopharma’s CTLA-4 and CD40 mAbs Approved for Phase II Clinical Trials by the FDA
BOSTON and BEIJING, July 6, 2021 --Eucure Biopharma, a wholly owned subsidiary of Biocytogen dedicated to developing antibody drugs with independent intellectual property rights, announced…
Read more
Biocytogen Completes a New Round of Financing Totaling Tens of Millions of Dollars
BEIJING and BOSTON, June 22, 2021- Biocytogen, an international biotechnology company focused on antibody drug research and development using innovative genetically engineered animal models, today…
Read more
Antibody Engineering & Therapeutics Virtual 2020
Presentation: Advancing Therapeutic Antibody discovery using RenMab/RenLite/RenMab KO immunoglobulin humanized mouse platforms Speaker: Li Hui, PhD, MD, Scientific Director of Biocytogen Boston Corp. Time: 9:30am…
Read more
Celebrating World CRISPR Day
Please fill out the form on the left side to consult with our gene editing specialist. To learn more, download gene editing services brochure.
Read more
Webinar: Antibody Discovery Platforms and RenMab Mouse
Biocytogen Chief Scientific Officer and Head of Drug Discovery, Benny Yang PhD. will speak on the current landscape of antibody discovery platforms, with special focus on fully human antibody mice. Dr. Yang will explain…
Read more